CanPath and its regional cohorts, including Atlantic PATH, are proud to be part of the COVID-19 Immunity Task Force (CITF) Databank with our COVID-19 serology study that includes participants across the country. The CITF Databank data holdings include data from 21 studies, including six multi-province studies “representing a wide range of population and community data from Read more about CITF COVID-19 Immunity Task Force Databank[…]
Dr. Victoria Kirsh presented at a CanPath webinar this week to present results from the SUPPORT-Canada study, funded by the federal COVID-19 Immunity Task Force (CITF). Data and blood spot samples were used from 22,300 participants from Atlantic PATH, CARTaGENE, the Ontario Health Study, Manitoba Tomorrow Project, Alberta’s Tomorrow Project, and BC Generations. Key findings include: Read more about Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19[…]
The Government of Canada is investing $1.9m through the COVID-19 Immunity Task Force (CITF) to fund an extension of CanPath’s COVID-19 Antibody Study over a longer period of time, allowing for additional collection of blood samples and questionnaires. The CanPath COVID-19 Antibody Study is implemented in collaboration with CanPath’s regional cohorts, including Atlantic PATH, CARTaGENE (Quebec), Read more about CanPath to Study the Impact and Immune Response to COVID-19 Infection and Vaccination[…]